Reprieve Cardiovascular
Milford, MA, United States · Healthcare, Health Care · 25 employees
Reprieve Cardiovascular Inc. is a startup focusing on developing an intelligent fluid management system for acute decompensated heart failure. Their technology aims to reduce the high rate of readmissions for heart failure patients by providing personalized diuretic dosing and fluid replacement.
Funding history
- Funding Round — $30.9M — Jun 2025
- Funding Round — $9.5M — Jan 2025
- Series seed — $5.0M — Oct 2024
- Series series a — $42.0M — Feb 2024
- Series series a — $42.0M — Feb 2024
Recent signals
- Jun 05, 2025: Raised $30.9M
- Jan 27, 2025: Raised $9.5M
- Oct 02, 2024: Raised $5.0M in Series seed
- Feb 21, 2024: Raised $42.0M in Series series a
- Feb 20, 2024: Raised $42.0M in Series series a
- Nov 20, 2023: Raised $12.1M
- Jun 08, 2022: Raised $15.0M
- Aug 04, 2020: Raised $15.0M
See plans & pricing → Track Reprieve Cardiovascular’s funding, hiring, and signals — with verified contacts — on Fundz.